Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database

Documenti analoghi

• A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
  di: Geier, David A., et al.
  Pubblicazione: (2014)
• The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)
  di: Geier, David A., et al.
  Pubblicazione: (2012)
• Adverse Events Following Quadrivalent Meningococcal CRM-Conjugate Vaccine (Menveo®) Reported to the Vaccine Adverse Event Reporting System (VAERS), 2010–2015
  di: Myers, Tanya R., et al.
  Pubblicazione: (2017)
• Adverse Events Following Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (Menactra®) Reported to the Vaccine Adverse Event Reporting System (VAERS), 2005–2016
  di: Myers, Tanya R., et al.
  Pubblicazione: (2020)
• Assessing the safety of 9-valent human papillomavirus vaccine administration among pregnant women: adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014–2017
  di: Landazabal, Claudia S., et al.
  Pubblicazione: (2019)